{"id":224115,"date":"2026-08-31T15:05:44","date_gmt":"2026-08-31T09:35:44","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=224115"},"modified":"2026-08-31T15:05:47","modified_gmt":"2026-08-31T09:35:47","slug":"bajaj-healthcare-overvalued-or-undervalued","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/bajaj-healthcare-overvalued-or-undervalued\/","title":{"rendered":"Is Bajaj Healthcare Overvalued or Undervalued Right Now?"},"content":{"rendered":"
<\/div>\n

Bajaj Healthcare CMP Rs 329.95 (31 Aug 2026), up 2.47%. PE 61.47 vs industry PE 51.43. ROE 8.81%. 52W range Rs 272.35 to Rs 515.90.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Bajaj Healthcare trades at a price to earnings ratio of 61.47 against an industry average of 51.43, which puts the stock close to fair value on a simple multiple basis rather than clearly overvalued or undervalued. The company’s 8.81% return on equity and Rs 158.34 book value per share fit broadly within its sector’s range. Whether Bajaj Healthcare is overvalued or undervalued right now is less about a wide valuation gap and more about how its growth and margins evolve from here.<\/p>\n<\/div>\n

Is Bajaj Healthcare<\/a> overvalued or undervalued right now is a question worth asking given how its price to earnings ratio compares with the rest of its sector. At the current market price of Rs 329.95, the stock trades roughly 36.0% below its 52 week high of Rs 515.90 and about 21.1% above its 52 week low of Rs 272.35.<\/p>\n

Bajaj Healthcare’s share price moved up 2.47% in Monday’s session to Rs 329.95, against a market capitalisation of Rs 1,084 Cr. This article looks at the numbers, the PE ratio, price to book, return on equity, debt levels and recent earnings trends, that determine whether the current price reflects fair value or a stretched multiple.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n